Stock listing
BOATS:INDV Indivior Pharmaceuticals, Inc. Stock
US listing (BOATS) of Indivior Pharmaceuticals, Inc. · home listing NASDAQ:INDV
Follow Indivior Pharmaceuticals, Inc. into a list and get an email when it puts out news.
Home listing price · NASDAQ:INDV
$34.79 USD +0.02 (+0.1%)
Close on Oct 21, 2026 · This listing has no price on 6ix; the price shown is the home listing's, NASDAQ:INDV
- Day range
- $34.56 – $35.15 USDOct 21, 2026
- Volume
- 3.24M sharesOct 21, 2026
- Market cap
- $4.11B USDAt the close on Oct 21, 2026 · price × 118.0M shares outstanding
Prices by listing
| Listing | Last | Change | Volume | Open | High | Low | Previous close | Price from |
|---|---|---|---|---|---|---|---|---|
| NASDAQ:INDV · Home | $34.79 USD | +0.02 (+0.1%) | 3,241,818 | $34.92 | $35.15 | $34.56 | $34.77 | Close on Oct 21, 2026 |
Daily closes
Last 3 months, Jul 21, 2026 – Oct 21, 2026 · NASDAQ:INDV · USD, adjusted for splits
| Day | Close | Change | % | Open | High | Low | Volume |
|---|---|---|---|---|---|---|---|
| $34.79 | +0.02 | +0.1% | $34.92 | $35.15 | $34.56 | 3,241,818 | |
| $34.77 | +0.90 | +2.7% | $34.02 | $35.12 | $33.80 | 1,923,349 | |
| $33.87 | +1.42 | +4.4% | $32.60 | $34.19 | $32.48 | 2,272,105 | |
| $32.45 | -1.17 | -3.5% | $33.47 | $33.76 | $32.31 | 4,205,894 | |
| $33.62 | -0.54 | -1.6% | $34.57 | $34.86 | $33.54 | 1,714,060 | |
| $34.16 | -1.26 | -3.6% | $35.11 | $36.30 | $33.99 | 2,761,792 | |
| $35.42 | -0.64 | -1.8% | $36.09 | $36.26 | $35.19 | 1,819,746 | |
| $36.06 | +0.23 | +0.6% | $36.00 | $36.32 | $35.37 | 6,419,336 | |
| $35.83 | +0.38 | +1.1% | $35.45 | $36.14 | $35.21 | 4,799,710 | |
| $35.45 | -0.68 | -1.9% | $35.73 | $36.35 | $34.85 | 1,527,166 | |
| $36.13 | +0.23 | +0.6% | $35.58 | $36.30 | $35.58 | 1,769,649 | |
| $35.90 | -0.09 | -0.3% | $35.96 | $36.15 | $35.03 | 2,390,500 | |
| $35.99 | +0.28 | +0.8% | $36.00 | $36.26 | $35.73 | 3,003,300 | |
| $35.71 | +0.33 | +0.9% | $35.46 | $36.15 | $35.26 | 1,669,300 | |
| $35.38 | -0.47 | -1.3% | $35.85 | $36.21 | $35.25 | 1,879,000 | |
| $35.85 | -0.74 | -2.0% | $36.54 | $36.60 | $35.79 | 1,673,600 | |
| $36.59 | -0.29 | -0.8% | $36.74 | $37.05 | $36.08 | 2,005,500 | |
| $36.88 | +1.06 | +3.0% | $35.50 | $36.96 | $35.43 | 1,173,500 | |
| $35.82 | -0.18 | -0.5% | $35.90 | $36.22 | $35.72 | 1,098,400 | |
| $36.00 | +0.09 | +0.3% | $35.71 | $36.28 | $35.57 | 2,221,700 | |
| $35.91 | -0.28 | -0.8% | $36.23 | $36.90 | $35.78 | 1,058,000 | |
| $36.19 | +0.66 | +1.9% | $35.53 | $36.63 | $35.48 | 2,216,100 | |
| $35.53 | +0.65 | +1.9% | $35.00 | $35.63 | $34.77 | 1,299,000 | |
| $34.88 | -0.81 | -2.3% | $35.59 | $35.62 | $34.59 | 4,684,200 | |
| $35.69 | +1.34 | +3.9% | $34.76 | $35.90 | $34.47 | 2,690,500 | |
| $34.35 | +0.13 | +0.4% | $33.97 | $34.54 | $33.84 | 1,865,900 | |
| $34.22 | -0.25 | -0.7% | $34.59 | $34.59 | $33.74 | 2,700,600 | |
| $34.47 | -0.02 | -0.1% | $34.74 | $35.01 | $34.15 | 3,429,300 | |
| $34.49 | -0.02 | -0.1% | $34.49 | $34.83 | $34.23 | 1,297,200 | |
| $34.51 | -0.26 | -0.7% | $34.58 | $34.87 | $34.04 | 1,319,500 | |
| $34.77 | +0.45 | +1.3% | $34.32 | $34.80 | $33.92 | 1,351,700 | |
| $34.32 | -0.62 | -1.8% | $34.35 | $34.84 | $33.84 | 1,823,800 | |
| $34.94 | +0.11 | +0.3% | $34.74 | $35.31 | $34.55 | 1,019,400 | |
| $34.83 | -0.22 | -0.6% | $35.18 | $35.23 | $34.57 | 1,825,600 | |
| $35.05 | +0.49 | +1.4% | $34.74 | $35.28 | $34.68 | 2,975,000 | |
| $34.56 | -0.37 | -1.1% | $35.00 | $35.44 | $34.50 | 2,094,800 | |
| $34.93 | +0.06 | +0.2% | $34.87 | $35.30 | $34.33 | 1,963,300 | |
| $34.87 | -0.43 | -1.2% | $35.31 | $35.49 | $34.49 | 3,308,700 | |
| $35.30 | -0.525 | -1.5% | $35.61 | $35.95 | $35.11 | 1,220,400 | |
| $35.83 | -0.145 | -0.4% | $35.90 | $36.21 | $35.55 | 1,275,300 | |
| $35.97 | -0.21 | -0.6% | $36.23 | $36.75 | $35.61 | 1,712,100 | |
| $36.18 | -0.69 | -1.9% | $36.53 | $36.82 | $35.37 | 1,840,800 | |
| $36.87 | -0.91 | -2.4% | $37.68 | $38.52 | $36.70 | 2,496,700 | |
| $37.78 | -1.26 | -3.2% | $38.91 | $39.25 | $37.64 | 1,442,300 | |
| $39.04 | -0.39 | -1.0% | $39.90 | $40.00 | $38.73 | 2,476,800 | |
| $39.43 | +0.35 | +0.9% | $39.48 | $39.92 | $39.08 | 2,338,600 | |
| $39.08 | +0.07 | +0.2% | $38.95 | $39.59 | $38.68 | 2,018,200 | |
| $39.01 | +0.79 | +2.1% | $38.00 | $39.14 | $37.82 | 988,400 | |
| $38.22 | -0.51 | -1.3% | $39.12 | $39.12 | $38.02 | 2,337,400 | |
| $38.73 | +0.30 | +0.8% | $38.50 | $39.15 | $37.86 | 2,572,400 | |
| $38.43 | -0.04 | -0.1% | $38.82 | $39.29 | $38.39 | 2,213,050 | |
| $38.47 | -0.35 | -0.9% | $38.09 | $39.09 | $37.95 | 2,065,719 | |
| $38.82 | +0.15 | +0.4% | $38.83 | $38.91 | $38.08 | 1,687,000 | |
| $38.67 | -0.06 | -0.2% | $39.04 | $39.74 | $38.53 | 2,676,300 | |
| $38.73 | +2.23 | +6.1% | $36.28 | $39.44 | $36.28 | 4,275,200 | |
| $36.50 | -0.87 | -2.3% | $37.94 | $38.04 | $35.76 | 7,154,900 | |
| $37.37 | -2.64 | -6.6% | $40.31 | $41.18 | $36.70 | 6,683,600 | |
| $40.01 | -0.21 | -0.5% | $39.96 | $40.31 | $38.63 | 1,351,800 | |
| $40.22 | +0.12 | +0.3% | $40.18 | $40.60 | $39.66 | 1,580,900 | |
| $40.10 | -0.89 | -2.2% | $41.28 | $41.65 | $39.97 | 1,496,200 | |
| $40.99 | +0.96 | +2.4% | $40.10 | $41.28 | $39.90 | 1,778,400 | |
| $40.03 | -0.495 | -1.2% | $40.62 | $40.99 | $40.01 | 997,200 | |
| $40.53 | +0.015 | 0.0% | $40.83 | $40.95 | $40.08 | 837,600 | |
| $40.51 | +0.06 | +0.1% | $39.81 | $40.71 | $39.65 | 2,386,600 | |
| $40.45 | 0.00 | 0.0% | $39.96 | $40.57 | $39.87 | 968,100 | |
| $40.45 | +1.33 | +3.4% | $39.02 | $40.57 | $38.56 | 1,840,400 |
- Ticker
- BOATS:INDV
- Asset type
- Stock
- Sector
- Health care
- Industry
- Pharmaceuticals
- Exchange
- BOATS
- Currency
- USD
What changed lately
Latest news release · Oct 19, 2026
Indivior to Report Third Quarter 2026 Financial Results
Latest earnings call · Aug 3, 2026
Indivior Pharmaceuticals (NASDAQ:INDV) Q2 2026 Earnings Call
Replay and transcript
Latest deck · Aug 3, 2026
Q2 2026 Earnings Presentation
Earnings · 25 slides
Calls
Replays
Indivior Pharmaceuticals (NASDAQ:INDV) Q2 2026 Earnings Call
Mon, Aug 03, 2026 · 8:00 AM ET
Watch TranscriptIndivior Pharmaceuticals (NASDAQ:INDV) Q1 2026 Earnings Call
Thu, Apr 30, 2026 · 8:00 AM ET
Watch TranscriptIndivior Pharmaceuticals (NASDAQ:INDV) Q4 2025 Earnings Call
Thu, Feb 26, 2026 · 8:00 AM ET
Watch Transcript
Latest news
Indivior to Report Third Quarter 2026 Financial Results
Oct 19, 2026
Closed $33.87 (+4.4%) on Oct 19, 2026
Shareholders Approve Proposed Merger with Supernus
Oct 15, 2026
Closed $32.45 (-3.5%) on Oct 16, 2026
Indivior Pharmaceuticals, Inc. Declares Special Cash Dividend
Sep 17, 2026
Closed $35.69 (+3.9%) on Sep 17, 2026
Indivior Reports Second Quarter 2026 Financial Results and Raises Full-Year 2026 Guidance
Aug 3, 2026
Closed $37.37 (-6.6%) on Aug 3, 2026
Indivior to Report Second Quarter 2026 Financial Results and Host Webcast
Jul 23, 2026
Closed $40.51 (+0.1%) on Jul 23, 2026
Decks
Q2 2026 Earnings Presentation
Earnings · 25 slides · Aug 3, 2026
Merger or Acquisition (August 2026)
Merger or acquisition · 13 slides · Aug 3, 2026
Q1 2026 Earnings Presentation
Earnings · 30 slides · Apr 30, 2026
Investor Presentation (April 2026)
Investor deck · 31 slides · April 2026
Indivior Pharmaceuticals, Inc. on 6ix
- Sector
- Health care
- Industry
- Pharmaceuticals
- News releases
- 29 in the last 12 months · 71 in all · newest Oct 19, 2026 · oldest 2023
- Calls
- 16 calls with a replay · 16 with a transcript · latest Aug 3, 2026
- Decks
- 30 decks · latest Aug 3, 2026
Where Indivior Pharmaceuticals, Inc. is listed
| Listing | Exchange | Country | Currency |
|---|---|---|---|
| NASDAQ:INDV · Home listing | NASDAQ | United States | USD |
| BOATS:INDV · This page | BOATS | United States | USD |
| Frankfurt:E7P | Frankfurt | Germany | EUR |
| Tradegate:E7P | Tradegate | Germany | EUR |
| BMV:INDV1 | BMV | Mexico | MXN |
| gettex:E7P | gettex | Germany | EUR |
| BIVA:INDV1 | BIVA | Mexico | MXN |
| Munich:E7P | Munich | Germany | EUR |
| Dusseldorf:E7P | Dusseldorf | Germany | EUR |
| Lang & Schwarz:A42086 | Lang & Schwarz | Germany | EUR |
| LS Exchange:A42086 | LS Exchange | Germany | EUR |
| Xetra:E7P | Xetra | Germany | EUR |
Log in to ask 6ix AI your own questions about Indivior Pharmaceuticals, Inc.